Squarepoint Ops LLC Sells 7,756 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

Squarepoint Ops LLC lowered its stake in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 17.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,268 shares of the company’s stock after selling 7,756 shares during the quarter. Squarepoint Ops LLC owned approximately 0.08% of KORU Medical Systems worth $140,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. First Light Asset Management LLC raised its holdings in KORU Medical Systems by 5.7% in the 4th quarter. First Light Asset Management LLC now owns 5,915,434 shares of the company’s stock valued at $22,774,000 after buying an additional 316,509 shares during the last quarter. Topline Capital Management LLC purchased a new position in KORU Medical Systems during the 4th quarter worth $16,660,000. Millennium Management LLC boosted its holdings in KORU Medical Systems by 4.5% during the 4th quarter. Millennium Management LLC now owns 283,710 shares of the company’s stock worth $1,092,000 after acquiring an additional 12,187 shares during the last quarter. White Pine Capital LLC boosted its holdings in shares of KORU Medical Systems by 25.6% in the 4th quarter. White Pine Capital LLC now owns 157,917 shares of the company’s stock worth $608,000 after buying an additional 32,176 shares during the last quarter. Finally, 683 Capital Management LLC purchased a new stake in shares of KORU Medical Systems during the 4th quarter worth approximately $340,000. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Price Performance

NASDAQ KRMD opened at $3.08 on Monday. The company has a market cap of $142.11 million, a PE ratio of -12.32 and a beta of 0.43. KORU Medical Systems, Inc. has a 52 week low of $1.86 and a 52 week high of $5.05. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The firm’s 50-day simple moving average is $2.66 and its two-hundred day simple moving average is $3.39.

KORU Medical Systems (NASDAQ:KRMD) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The company had revenue of $9.64 million for the quarter, compared to the consensus estimate of $8.86 million. KORU Medical Systems had a negative net margin of 37.42% and a negative return on equity of 24.60%. Research analysts predict that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on KRMD shares. B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a research note on Thursday, March 13th. Piper Sandler dropped their price objective on shares of KORU Medical Systems from $4.50 to $3.50 and set a “neutral” rating on the stock in a report on Thursday, May 8th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $4.50.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.